Delivery Order SPE2DB25D3020-SPE2DB25FWHZN

Award Date 6/13/25
Potential Completion Date 6/16/25
Potential Value $5.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,729.48 firm fixed-price contract is for the supply of JANUMET XR 50-1,000 MG tablets, a medication used to treat type 2 diabetes. The contract has an ultimate completion date of November 30, 2023 and was awarded on November 29, 2022. This delivery order is part of a larger $999,999,999 Indefinite Delivery...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,726.26, is for the delivery of JANUMET XR 50-1,000 MG TABLET 60S, a prescription medication used for the treatment of type 2 diabetes. The contract has a firm fixed price pricing type and an ultimate completion date of October 14, 2022. This Delivery Order contract is a part of a larger...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $10,002.02 contract is for the delivery of JANUMET XR 50-1,000 MG TABLET 180S, a medication for diabetes management. This contract is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,892.86, is for the delivery of JANUMET XR 50-1,000 MG TABLET 180S, a prescription medication used to manage diabetes. The contract has an ultimate completion date of October 6, 2023 and is a firm fixed-price delivery order with no set-aside designation....
This is a $16,138.76 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of JANUMET XR 50-1,000 MG TABLET 180S, a prescription medication used to treat type 2 diabetes. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Janumet XR 50-1,000 mg tablets, a medication used to treat type 2 diabetes. The award has a ceiling value of $40,011.41 and a completion date of September 6, 2023. The contract is not set aside and is part of a larger Indefinite Delivery Contract (IDC) valued at...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with an ultimate completion date of January 29, 2025, is for the delivery of JANUMET XR 50-1,000 MG tablets, a prescription medication used to treat type 2 diabetes. The contract has a ceiling value of $1,224.35. This award is part of Amerisourcebergen's larger Indefinite Delivery...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Janumet XR 50-1,000 MG tablets, a medication used to treat type 2 diabetes. The contract has a ceiling value of $2,182.53 and is a firm fixed-price delivery order contract with a performance period through May 22, 2025. The contract is not set-aside and was awarded...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Janumet XR 50-1,000 mg tablets, a medication used to treat type 2 diabetes. The contract has a firm fixed price of $1,620.97 and a completion date of April 29, 2025. This award is not a set-aside and was competed openly. AmerisourceBergen Drug Corp also holds a larger Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of JANUMET XR 50-1,000 MG tablets, a medication used to manage diabetes. The contract has a ceiling value of $2,433.17 and runs through December 27, 2024. The contract is a firm-fixed-price delivery order, meaning the price is set and will not change. This appears to be a task order...
  • SPE2DB25D3020
    Indefinite Delivery Contract
  • SPE2DB25D3020-SPE2DB25FWHZN
    Delivery Order

This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 180 tablets of Janumet XR 50-1,000 mg, a medication used to treat type 2 diabetes. The contract has a firm fixed price of $5,254.26 and a completion date of June 16, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that AmerisourceBergen holds with the DLA, which provides a comprehensive global pharmaceutical support vehicle for military healthcare programs through December 2026. The contract is not set aside for any particular business type.

Generated 9/12/25, 10:58 AM